LV10792A - Neirotrofins 3 jauns smadzenu neirotrofiska faktora un nervu augsanas faktora saimes faktors - Google Patents

Neirotrofins 3 jauns smadzenu neirotrofiska faktora un nervu augsanas faktora saimes faktors

Info

Publication number
LV10792A
LV10792A LV931135A LV931135A LV10792A LV 10792 A LV10792 A LV 10792A LV 931135 A LV931135 A LV 931135A LV 931135 A LV931135 A LV 931135A LV 10792 A LV10792 A LV 10792A
Authority
LV
Latvia
Prior art keywords
factor
neurotrophic
brain
nerve growth
protein
Prior art date
Application number
LV931135A
Other languages
English (en)
Other versions
LV10792B (en
Inventor
Andreas Hohn
Joachim Leibrock
Karen Bailey
Yves-Alain Barde
Hans Friedrich Erwin Thoenen
Peter C Maisonpierre
Mark E Furth
Ronald M Lindsay
George Yancopoulos
Original Assignee
Max Planck Gesellschaft
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/400,591 external-priority patent/US5180820A/en
Application filed by Max Planck Gesellschaft, Regeneron Pharma filed Critical Max Planck Gesellschaft
Publication of LV10792A publication Critical patent/LV10792A/lv
Publication of LV10792B publication Critical patent/LV10792B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-93-1135A 1989-08-30 1993-10-06 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor LV10792B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/400,591 US5180820A (en) 1989-08-30 1989-08-30 Brain-derived neurotrophic factor
US49000490A 1990-03-07 1990-03-07
US57018990A 1990-08-20 1990-08-20
PCT/US1990/004916 WO1991003569A1 (en) 1989-08-30 1990-08-29 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor

Publications (2)

Publication Number Publication Date
LV10792A true LV10792A (lv) 1995-08-20
LV10792B LV10792B (en) 1995-12-20

Family

ID=27410411

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1135A LV10792B (en) 1989-08-30 1993-10-06 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor

Country Status (21)

Country Link
EP (1) EP0441947B1 (lv)
KR (1) KR100196203B1 (lv)
CN (1) CN1124342C (lv)
AT (1) ATE153074T1 (lv)
AU (1) AU643705B2 (lv)
CA (1) CA2040437C (lv)
CZ (1) CZ286015B6 (lv)
DE (1) DE69030719T2 (lv)
ES (1) ES2100891T3 (lv)
FI (1) FI105343B (lv)
GR (1) GR1000980B (lv)
HK (1) HK1006579A1 (lv)
IE (1) IE903129A1 (lv)
IL (1) IL95511A (lv)
LV (1) LV10792B (lv)
NO (1) NO303694B1 (lv)
NZ (1) NZ235086A (lv)
PT (1) PT95153B (lv)
SG (1) SG70560A1 (lv)
SK (1) SK279660B6 (lv)
WO (1) WO1991003569A1 (lv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
US5986070A (en) * 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
ATE154389T1 (de) * 1991-02-18 1997-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von menschlichem ngf-2
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
RU94016525A (ru) * 1991-07-10 1996-06-10 Ридженерон Фармасьютикалз Способы лечения заболеваний двигательных нейронов
DE4237047A1 (en) * 1991-11-04 1993-05-06 I N R O Handels-Gmbh, 8750 Aschaffenburg, De Drug contg. polypeptide homologous to nerve growth factor and slow virus sequence - for treating amyotrophic lateral sclerosis, spinal muscle atrophy or Parkinson's disease
EP0573904B1 (en) * 1992-06-08 2001-09-26 Takeda Chemical Industries, Ltd. Therapeutic agent for neutropenia
WO1993025684A1 (en) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
ES2149823T3 (es) * 1992-09-03 2000-11-16 Univ California Factor y composiciones que afectan al tejido dorsal.
WO1994011384A1 (en) * 1992-11-13 1994-05-26 Immunex Corporation Novel cytokine designated elk ligand
CA2117889A1 (en) * 1993-02-11 1994-08-18 Martin E. Schwab A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
EP0753013A1 (en) * 1994-03-29 1997-01-15 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Neurotrophin-6: a new member of the neurotrophin family
AU2460595A (en) * 1994-05-06 1995-11-29 Regeneron Pharmaceuticals, Inc. Methods based on the role of neurotrophin 3 in female reproduction
US6303769B1 (en) 1994-07-08 2001-10-16 Immunex Corporation Lerk-5 dna
JP3738281B2 (ja) * 1994-07-22 2006-01-25 アベンティス ファーマ株式会社 新規な骨芽細胞増殖因子
US5770577A (en) * 1994-11-14 1998-06-23 Amgen Inc. BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
CA2206994A1 (en) * 1994-12-05 1996-06-13 Hans-Werner Muller Genes and gene products for use in the diagnosis of degenerative nerve damage
US5859311A (en) * 1995-11-27 1999-01-12 University Of Kentucky Research Foundation Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use
AU2800797A (en) 1996-04-05 1997-10-29 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
EP0969875B1 (en) * 1997-01-17 2008-11-26 Aventis Pharma S.A. Naked dna-mediated gene transfer into medullary motor neurons
AU718500B2 (en) 1997-01-23 2000-04-13 Sumitomo Pharmaceuticals Company, Limited Remedies for diabetes
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
ATE343793T1 (de) * 1999-05-03 2006-11-15 Evotec Ag Methode zur diagnostizierung, prognose oder evaluation von behandlung der depressionen, basiert auf erhöhte neurotrophin concentrationen in zerebrospinale flüssigkeit.
CN1112215C (zh) * 1999-12-28 2003-06-25 潘晓东 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途
CA2412494C (en) * 2000-06-22 2012-10-23 Genentech, Inc. Agonist anti-trk-c monoclonal antibodies
WO2006108651A2 (en) * 2005-04-12 2006-10-19 Develogen Aktiengesellschaft Use of activin products for preventing and treating diabetes and/or metabolic syndrome
US20140294732A1 (en) 2011-11-08 2014-10-02 Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute Early diagnostic of neurodegenerative diseases
US20140314787A1 (en) 2011-11-08 2014-10-23 Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute Treatment for neurodegenerative diseases
WO2014006114A1 (en) 2012-07-05 2014-01-09 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research New treatment for neurodegenerative diseases
CN110862447A (zh) * 2019-11-29 2020-03-06 武汉赛维尔生物科技有限公司 一种提高神经营养因子nt-3碱性蛋白产量的蛋白改造方法
CN113940308A (zh) * 2021-04-28 2022-01-18 重庆腾达牧业有限公司 大足黑山羊哺乳舍饲养管理方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699875A (en) * 1982-11-24 1987-10-13 Baylor College Of Medicine Diagnosis of amyotrophic lateral sclerosis by neurotrophic factors
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US6709837B1 (en) * 1989-03-10 2004-03-23 Takeda Chemical Industries, Inc. Polypeptide and production thereof
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
US7020718B2 (en) 2000-05-15 2006-03-28 Hewlett-Packard Development Company, L.P. System and method of aggregating discontiguous address ranges into addresses and masks using a plurality of repeating address blocks

Also Published As

Publication number Publication date
NO303694B1 (no) 1998-08-17
LV10792B (en) 1995-12-20
KR920702865A (ko) 1992-10-28
GR900100647A (en) 1991-12-30
NO911688L (no) 1991-05-31
CZ286015B6 (cs) 1999-12-15
CZ423090A3 (cs) 1999-09-15
ATE153074T1 (de) 1997-05-15
WO1991003569A1 (en) 1991-03-21
HK1006579A1 (en) 1999-03-05
GR1000980B (el) 1993-03-31
PT95153B (pt) 1993-12-31
FI912105A0 (fi) 1991-04-30
DE69030719T2 (de) 1997-09-25
CN1052141A (zh) 1991-06-12
ES2100891T3 (es) 1997-07-01
CN1124342C (zh) 2003-10-15
KR100196203B1 (ko) 1999-06-15
EP0441947A4 (en) 1992-05-13
IL95511A (en) 2000-10-31
EP0441947B1 (en) 1997-05-14
IL95511A0 (en) 1991-06-30
CA2040437C (en) 2002-10-22
SK423090A3 (en) 1999-02-11
NZ235086A (en) 1993-10-26
SG70560A1 (en) 2000-02-22
DE69030719D1 (de) 1997-06-19
AU643705B2 (en) 1993-11-25
IE903129A1 (en) 1991-03-13
PT95153A (pt) 1991-05-22
NO911688D0 (no) 1991-04-29
AU6404990A (en) 1991-04-08
SK279660B6 (sk) 1999-02-11
EP0441947A1 (en) 1991-08-21
FI105343B (fi) 2000-07-31
CA2040437A1 (en) 1991-03-01

Similar Documents

Publication Publication Date Title
LV10792A (lv) Neirotrofins 3 jauns smadzenu neirotrofiska faktora un nervu augsanas faktora saimes faktors
DE59006837D1 (de) Verfahren zur fermentativen Herstellung von Aminosäuren, insbesondere L-Lysin, dafür geeignete Mikroorganismen und rekombinante DNA.
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
DK1218509T3 (da) Fibroblast vækstfaktorlignende polypeptider
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
DE3884356D1 (de) Verfahren zur Herstellung von Fremdprotein in Hefe, Rekombinant DNS, Transformant.
ATE187775T1 (de) Verfahren zur herstellung von menschlichem serumalbumin in hefe
ATE123060T1 (de) Tgf-beta induziertes gen und protein.
DE69634043D1 (de) Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie
ATE195346T1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE391175T1 (de) Multidrug resistenz gen
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
DE59005821D1 (de) Verfahren zur Herstellung von L-Isoleucin und dafür geeignete Mikroorganismen und rekombinante DNA.
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
DE3751249D1 (de) Protein L und ihre Untereinheiten, mit immunglobulinbindender Aktivität, Verfahren zur Herstellung, Reagenssatz, pharmazeutische Zubereitung und ein Peptococcus-magnus-Stamm.
EP0293827A3 (en) Assay for leishmaniasis
DE3786870D1 (de) Methode zur herstellung von proteinen.
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
DE69033553D1 (de) Rekombinante herstellung von laktoperoxidase
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
DE3783425D1 (de) Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
ATE92528T1 (de) Methode zur herstellung von proteinen.